US FDA’s Califf Responds To, And Deflects, Senators’ Mifepristone Questions

The Senate Appropriations Subcommittee hearing was called to discuss the agency’s FY 2024 budget request, but several committee members wanted to talk about the pending Supreme Court decision on the medication abortion drug.